Abstract
The renin angiotensin system (RAS) is involved not only in the regulation of blood pressure and fluid homeostasis, but also in the modulation of multiple additional functions in the brain. In this sense, it was found to be involved in many neuroadaptive responses induced by drugs such as cocaine, amphetamines, alcohol, as well as others.
It is known that the dopaminergic neurotransmission in the nucleus accumbens and caudate-putamen plays a critical role in the rewarding effects of psychostimulant drugs and alcohol. The main and more studied actions of RAS are mediated by the neuropeptide Angiotensin II (Ang II) that belongs to the group of peptides known to stimulate dopamine release.
There is growing evidence showing the key role of RAS in the development of neuroadaptive changes related to behavioral sensitization induced by natural reinforcers and drugs known to be abused. Recently, we found evidence involving the AT1 receptors in the neuroadaptive changes induced by amphetamine. Moreover, others found evidence that Ang II AT1 receptors are strongly involved in ethanol intake in rodents.
Our goal is to present and discuss the evidence supporting an important role of brain RAS in neuroadaptive responses induced by two of the most abused drugs: amphetamine and alcohol, proposing this system as a potential therapeutic target in the treatment of disorders related to these drugs of choice for abuse.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allen AM, Zhuo J, Mendelsohn FA. Localization and function of angiotensin AT1 receptors. Am J Hypertens. 2000;13(1 Pt 2):31S–8.
Lenkei Z, Palkovits M, Corvol P, Llorens-Cortes C. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol. 1997;18(4):383–439.
Bader M, Ganten D. It’s renin in the brain: transgenic animals elucidate the brain renin angiotensin system. Circ Res. 2002;90(1):8–10.
Campbell DJ. Angiotensin peptides in the brain. Adv Exp Med Biol. 1995;377:349–55.
Phillips MI. Functions of angiotensin in the central nervous system. Annu Rev Physiol. 1987;49:413–35.
Pan HL. Brain angiotensin II and synaptic transmission. Neuroscientist. 2004;10(5):422–31.
Ferguson AV, Bains JS. Actions of angiotensin in the subfornical organ and area postrema: implications for long term control of autonomic output. Clin Exp Pharmacol Physiol. 1997;24(1):96–101.
Ferguson AV, Washburn DL, Latchford KJ. Hormonal and neurotransmitter roles for angiotensin in the regulation of central autonomic function. Exp Biol Med (Maywood). 2001;226(2):85–96.
Brown DC, Steward LJ, Ge J, Barnes NM. Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo. Br J Pharmacol. 1996;118(2):414–20.
Daubert DL, Meadows GG, Wang JH, Sanchez PJ, Speth RC. Changes in angiotensin II receptors in dopamine-rich regions of the mouse brain with age and ethanol consumption. Brain Res. 1999;816(1):8–16.
Wright JW, Harding JW. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci Biobehav Rev. 1994;18(1):21–53.
Stornetta RL, Hawelu-Johnson CL, Guyenet PG, Lynch KR. Astrocytes synthesize angiotensinogen in brain. Science. 1988;242(4884):1444–6.
Ganong WF. Origin of the angiotensin II secreted by cells. Proc Soc Exp Biol Med. 1994;205(3):213–9.
Chai SY, Mendelsohn FA, Paxinos G. Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography. Neuroscience. 1987;20(2):615–27.
Johnston CI. Biochemistry and pharmacology of the renin-angiotensin system. Drugs. 1990;39 Suppl 1:21–31.
Lippoldt A, Paul M, Fuxe K, Ganten D. The brain renin-angiotensin system: molecular mechanisms of cell to cell interactions. Clin Exp Hypertens. 1995;17(1–2):251–66.
Saavedra JM. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol. 2005;25(3–4):485–512.
Bumpus FM, Catt KJ, Chiu AT, DeGasparo M, Goodfriend T, Husain A, et al. Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension. 1991;17(5):720–1.
Lind RW, Swanson LW, Ganten D. Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. An immunohistochemical study. Neuroendocrinology. 1985;40(1):2–24.
Song K, Allen AM, Paxinos G, Mendelsohn FA. Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J Comp Neurol. 1992;316(4):467–84.
Allen AM, Moeller I, Jenkins TA, Zhuo J, Aldred GP, Chai SY, et al. Angiotensin receptors in the nervous system. Brain Res Bull. 1998;47(1):17–28.
Wright JW, Harding JW. Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res Brain Res Rev. 1992;17(3):227–62.
Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev. 1977;57(2):313–70.
Bunnemann B, Fuxe K, Ganten D. The renin-angiotensin system in the brain: an update 1993. Regul Pept. 1993;46(3):487–509.
Mendelsohn FA, Allen AM, Chai SY, McKinley MJ, Oldfield BJ, Paxinos G. The brain angiotensin system: insights from mapping its components. Trends Endocrinol Metab. 1990;1(4):189–98.
Tchekalarova J, Pechlivanova D, Kambourova T, Matsoukas J, Georgiev V. The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception. Regul Pept. 2003;111(1–3):191–7.
Denny JB, Polan-Curtain J, Wayner MJ, Armstrong DL. Angiotensin II blocks hippocampal long-term potentiation. Brain Res. 1991;567(2):321–4.
Pederson ES, Harding JW, Wright JW. Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog. Regul Pept. 1998;74(2–3):97–103.
Georgiev V, Getova D, Opitz M. Mechanisms of the angiotensin II effects on the exploratory behavior of rats in open field. I. Interaction of angiotensin II with saralasin and catecholaminergic drugs. Methods Find Exp Clin Pharmacol. 1987;9(5):297–301.
Gard PR. The role of angiotensin II in cognition and behaviour. Eur J Pharmacol. 2002;438(1–2):1–14.
Raghavendra V, Chopra K, Kulkarni SK. Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan. Neuropeptides. 1998;32(3):275–80.
Tchekalarova J, Georgiev V. Further evidence for interaction between angiotensin II and dopamine receptors (experiments on apomorphine stereotypy). Methods Find Exp Clin Pharmacol. 1998;20(5):419–24.
Banks RJ, Mozley L, Dourish CT. The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat. Neuroscience. 1994;58(4):799–805.
Gelband CH, Sumners C, Lu D, Raizada MK. Angiotensin receptors and norepinephrine neuromodulation: implications of functional coupling. Regul Pept. 1998;73(3):141–7.
Nahmod VE, Finkielman S, Benarroch EE, Pirola CJ. Angiotensin regulates release and synthesis of serotonin in brain. Science. 1978;202(4372):1091–3.
Barnes KL, DeWeese DM, Andresen MC. Angiotensin potentiates excitatory sensory synaptic transmission to medial solitary tract nucleus neurons. Am J Physiol Regul Integr Comp Physiol. 2003;284(5):R1340–53.
Oz M, Yang KH, O’Donovan MJ, Renaud LP. Presynaptic angiotensin II AT1 receptors enhance inhibitory and excitatory synaptic neurotransmission to motoneurons and other ventral horn neurons in neonatal rat spinal cord. J Neurophysiol. 2005;94(2):1405–12.
Rodriguez-Pallares J, Quiroz CR, Parga JA, Guerra MJ, Labandeira-Garcia JL. Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors. Eur J Neurosci. 2004;20(6):1489–98.
Allen AM, MacGregor DP, Chai SY, Donnan GA, Kaczmarczyk S, Richardson K, et al. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Ann Neurol. 1992;32(3):339–44.
Allen AM, Paxinos G, McKinley MJ, Chai SY, Mendelsohn FA. Localization and characterization of angiotensin II receptor binding sites in the human basal ganglia, thalamus, midbrain pons, and cerebellum. J Comp Neurol. 1991;312(2):291–8.
McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, et al. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol. 2003;35(6):901–18.
von Bohlen und Halbach O, Albrecht D. The CNS renin-angiotensin system. Cell Tissue Res. 2006;326(2):599–616.
Allen AM, MacGregor DP, McKinley MJ, Mendelsohn FA. Angiotensin II receptors in the human brain. Regul Pept. 1999;79(1):1–7.
Barnes JM, Steward LJ, Barber PC, Barnes NM. Identification and characterisation of angiotensin II receptor subtypes in human brain. Eur J Pharmacol. 1993;230(3):251–8.
Mendelsohn FA, Jenkins TA, Berkovic SF. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res. 1993;613(2):221–9.
Jenkins TA, Mendelsohn FA, Chai SY. Angiotensin-converting enzyme modulates dopamine turnover in the striatum. J Neurochem. 1997;68(3):1304–11.
Georgiev V, Gyorgy L, Getova D, Markovska V. Some central effects of angiotensin II. Interactions with dopaminergic transmission. Acta Physiol Pharmacol Bulg. 1985;11(4):19–26.
Georgiev V, Stancheva S, Kambourova T, Getova D. Effect of angiotensin II on the Vogel conflict paradigm and on the content of dopamine and noradrenaline in rat brain. Acta Physiol Pharmacol Bulg. 1990;16(1):32–7.
Jenkins TA, Chai SY, Howells DW, Mendelsohn FA. Intrastriatal angiotensin II induces turning behaviour in 6-hydroxydopamine lesioned rats. Brain Res. 1995;691(1–2):213–6.
Hoebel BG, Rada P, Mark GP, Hernandez L. The power of integrative peptides to reinforce behavior by releasing dopamine. Ann N Y Acad Sci. 1994;739:36–41.
Nicolaidis S. Role des recepteurs internes et externes dans la prise d’eau regulatrice et non regulatrice. In: In Rein et Foie, Maladies de la Nutrition; 1974. p. 159–74.
Xue B, Zhang Z, Johnson RF, Johnson AK. Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment. Hypertension. 2012;59(2):459–66.
Clark JJ, Bernstein IL. Reciprocal cross-sensitization between amphetamine and salt appetite. Pharmacol Biochem Behav. 2004;78(4):691–8.
Kalivas PW. Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity. Dialogues Clin Neurosci. 2007;9(4):389–97.
Stewart J, Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol. 1993;4(4):289–312.
Pierce RC, Kalivas PW. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev. 1997;25(2):192–216.
Vanderschuren LJ, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl). 2000;151(2–3):99–120.
Valjent E, Bertran-Gonzalez J, Aubier B, Greengard P, Herve D, Girault JA. Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol. Neuropsychopharmacology. 2010;35(2):401–15.
Vanderschuren LJ, Schmidt ED, De Vries TJ, Van Moorsel CA, Tilders FJ, Schoffelmeer AN. A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J Neurosci. 1999;19(21):9579–86.
Kalivas PW, Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev. 1991;16(3):223–44.
Na ES, Morris MJ, Johnson RF, Beltz TG, Johnson AK. The neural substrates of enhanced salt appetite after repeated sodium depletions. Brain Res. 2007;1171:104–10.
Voorhies AC, Bernstein IL. Induction and expression of salt appetite: effects on Fos expression in nucleus accumbens. Behav Brain Res. 2006;172(1):90–6.
Roitman MF, Na E, Anderson G, Jones TA, Bernstein IL. Induction of a salt appetite alters dendritic morphology in nucleus accumbens and sensitizes rats to amphetamine. J Neurosci. 2002;22(11):RC225.
Acerbo MJ, Johnson AK. Behavioral cross-sensitization between DOCA-induced sodium appetite and cocaine-induced locomotor behavior. Pharmacol Biochem Behav. 2011;98(3):440–8.
Paz MC, Assis MA, Cabrera RJ, Cancela LM, Bregonzio C. The AT angiotensin II receptor blockade attenuates the development of amphetamine-induced behavioral sensitization in a two-injection protocol. Synapse. 2011;65(6):505–12.
Paz M, Marchese M, Cancela L, Bregonzio C. Angiotensin II AT1 receptors are involved in neuronal activation induced by amphetamine in a two-injection protocol. BioMed Res Int. 2013;2013: 534817.
Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993;18(3):247–91.
Paz MC, Marchese NA, Stroppa MM, Gerez de Burgos NM, Imboden H, Baiardi G, et al. Involvement of the brain renin-angiotensin system (RAS) in the neuroadaptive responses induced by amphetamine in a two-injection protocol. Behav Brain Res. 2014;272C:314–23.
Straus R. Alcohol and alcohol problems. The United States. Br J Addict. 1986;81(10):315–25.
Grup L. The renin-angiotensin system: a multidimensional source of control over alcohol consumption. Alcohol Suppl. 1991; 1:421–6.
Grupp L, Harding S.The reduction in alcohol drinking by peripherally injected angiotensin II is selectively mediated by the AT1 receptor subtype.Pharmacol Biochem Behav. 1994; 47(3):385–92.
Spinosa G, Perlanski E, Leenen F, Stewart R, Grupp L. Angiotensin converting enzyme inhibitors: animal experiments suggest a new pharmacological treatment for alcohol abuse in man. Alcohol Clin Exp Res. 1988;12:65–70.
Katner S, Weiss F. Neurochemical characteristics associated with ethanol preference in selected alcohol-preferring and -nonpreferring rats: a quantitative microdialysis study. Alcohol Clin Exp Res. 2001;25(2):198–205.
Gessa G, Muntoni F, Collu M, Vargiu L, Mereu G. Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res. 1985;348(1):201–3.
Brodie M, Shefner S, Dunwiddie T. Ethanol increases the firing rate of dopamine neurons of the rat ventral tegmental area in vitro. Brain Res. 1990;508(1):65–9.
Brodie M, Pesold C, Appel S. Ethanol directly excites dopaminergic ventral tegmental area reward neurons. Alcohol Clin Exp Res. 1999;23(11):1848–52.
Di Chiara G, Imperato A. Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur J Pharmacol. 1985;115(1):131–2.
Yim H, Gonzales R. Ethanol-induced increases in dopamine extracellular concentration in rat nucleus accumbens are accounted for by increased release and not uptake inhibition. Alcohol. 2000;22(2):107–15.
Yoshimoto K, McBride W, Lumeng L, Li T. Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol. 1992;9(1):17–22.
Yoshimoto K, McBride W, Lumeng L, Li T. Ethanol enhances the release of dopamine and serotonin in the nucleus accumbens of HAD and LAD lines of rats. Alcohol Clin Exp Res. 1992;16(4):781–5.
Katner S, Kerr T, Weiss F. Ethanol anticipation enhances dopamine efflux in the nucleus accumbens of alcohol-preferring (P) but not Wistar rats. Behav Pharmacol. 1996;7(7):669–74.
Melendez R, Rodd-Henricks Z, Engleman E, Li T, McBride W, Murphy J. Microdialysis of dopamine in the nucleus accumbens of alcohol-preferring (P) rats during anticipation and operant self-administration of ethanol. Alcohol Clin Exp Res. 2002;26(3):318–25.
Weiss F, Lorang M, Bloom F, Koob G. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther. 1993;267(1):250–8.
Deehan J, Engleman E, Ding Z, McBride W, Rodd Z. Microinjections of acetaldheyde or salsolinol into the posterior ventral tegmental area increase dopamine release in the nucleus accumbens shell. Alcohol Clin Exp Res. 2013;37(5):722–729.
Sommer WH, Saavedra JM. Targeting brain angiotensin and corticotrophin-releasing hormone systems interaction for the treatment of mood and alcohol use disorders. J Mol Med. 2008;86(6):723–8.
Sommer WH, Rimondini R, Marquitz M, Lidstrom J, Siems WE, Bader M, et al. Plasticity and impact of the central renin-angiotensin system during development of ethanol dependence. J Mol Med (Berl). 2007;85(10):1089–97.
Maul B, Siems W, Hoehe M, Grecksch G, Bader M, Walther T. Alcohol consumption is controlled by angiotensin II. FASEB J. 2001;15(9):1640–2.
Maul B, Krause W, Pankow K, Becker M, Gembardt F, Alenina N, et al. Central angiotensin II controls alcohol consumption via its AT1 receptor. FASEB J. 2005;19(11):1474–81.
Phillips T, Brown K, Burkhart-Kasch S, Wenger C, Kelly M, Rubinstein M, et al. Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptor. Nat Neurosci. 1998;1:610–5.
Weisinger R, Blair-West J, Denton D, McBurnie M. Angiotensin II stimulates intake of ethanol in C57BL/6J mice. Physiol Behav. 1999;67(3):369–76.
Koutsoukos G, Harding S, Grupp L. Increased alcohol consumption in weight-reduced rats is modulated by the renin-angiotensin system. Alcohol. 1995;12(1):23–8.
Fitts D. Angiotensin and captopril increase alcohol intake. Pharmacol Biochem Behav. 1993;45(1):35–43.
Grupp L, Harding S. Intracerebroventricularly infused angiotensin II or III do not alter voluntary alcohol intake in rats. Pharmacol Biochem Behav. 1995;51(4):593–9.
Grupp L. Effects of angiotensin II and an angiotensin converting enzyme inhibitor on alcohol intake in P and NP rats. Pharmacol Biochem Behav. 1992;41(1):105–8.
Lingham T, Perlanski E, Grupp L. Angiotensin converting enzyme inhibitors reduce alcohol consumption: some possible mechanisms and important conditions for its therapeutic use. Alcohol Clin Exp Res. 1990;14(1):92–9.
Grupp L, Chow S. Time-dependent effect of the angiotensin converting enzyme inhibitor, abutapril, on voluntary alcohol intake in the rat. Alcohol Alcohol. 1992;27(3):267–71.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Paz, M.C., Marchese, N.A., Bregonzio, C., Baiardi, G.C. (2015). Brain Renin-Angiotensin System: A Novel Therapeutic Target for Psychostimulant and Alcohol Related Disorders?. In: Gargiulo, P., Arroyo, H. (eds) Psychiatry and Neuroscience Update. Springer, Cham. https://doi.org/10.1007/978-3-319-17103-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-17103-6_7
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17102-9
Online ISBN: 978-3-319-17103-6
eBook Packages: MedicineMedicine (R0)